CABP2 Patient Registry and Natural History Study
Recruiting
Observational Study
CABP2-related Auditory Synaptopathy
Hearing Impairment
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Sex
- Any
- Study type
- Observational
- Participants needed
- 100 (estimated)
- Sponsor
- University Medical Center Goettingen · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This registry is designed to collect comprehensive information about the molecular genetic diagnoses and clinical information of individuals with CABP2-associated hearing impairment to support a natural history study.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* A molecular genetic diagnosis involving biallelic variants in CAPB2 and audiometry
Exclusion Criteria:
* Patients with evidence of non-CABP2 molecular genetic diagnoses
Contacts